
Pharmacokinetics and dosimetry of 188Re-pharmaceuticals
Keywords: Rhenium-188; Cancer therapy; Lymphoma; Beta emitters in cancer; Radiopeptides; Specific targeting; Radioimmunotherapy; Peptide receptors radionuclide therapy